High density lipoprotein uptake by scavenger receptor SR-BII.
Scavenger receptor class B, type I (SR-BI) mediates selective uptake of high density lipoprotein (HDL) lipids. It is unclear whether this process occurs at the cell membrane or via endocytosis. Our group previously identified an alternative mRNA splicing variant of SR-BI, named SR-BII, with an entirely different, yet highly conserved cytoplasmic C terminus. In this study we aimed to compare HDL uptake by both isoforms. Whereas SR-BI was mainly ( approximately 70%) localized on the surface of transfected Chinese hamster ovary cells, as determined by biotinylation, HDL binding at 4 degrees C, and studies of enhanced green fluorescent protein-tagged SR-BI/II fusion proteins, the majority of SR-BII ( approximately 80-90%) was expressed intracellularly. The cellular distribution of SR-BI was not affected by deletion of the C terminus, which suggests that the distinct C terminus of SR-BII is responsible for its intracellular expression. Pulse-chase experiments showed that SR-BII rapidly internalized HDL protein, whereas in the case of SR-BI most HDL protein remained surface bound. Like its ligand, SR-BII was more rapidly endocytosed compared with SR-BI. Despite more rapid HDL uptake by SR-BII than SR-BI, selective cholesteryl ether uptake was significantly lower. Relative to their levels of expression at the cell surface, however, both isoforms mediated selective uptake with similar efficiency. HDL protein that was internalized by SR-BII largely co-localized with transferrin in the endosomal recycling compartment. Within the endosomal recycling compartment of SR-BII cells, there was extensive co-localization of internalized HDL lipid and protein. These results do not support a model that selective lipid uptake by SR-BI requires receptor/ligand recycling within the cell. We conclude that SR-BII may influence cellular cholesterol trafficking and homeostasis in a manner that is distinct from SR-BI.
Eckhardt
Erik R M
ER
Department of Internal Medicine, University of Kentucky, Lexington, Kentucky 40536, USA.
Cai
Lei
L
Sun
Bing
B
Webb
Nancy R
NR
van der Westhuyzen
Deneys R
DR
D017398:Alternative Splicing; D000818:Animals; D016466:CHO Cells; D019556:COS Cells; D008076:Cholesterol, HDL / Q000493:pharmacokinetics*; D006224:Cricetinae; D004705:Endocytosis / Q000502:physiology; D011992:Endosomes / Q000378:metabolism; D006706:Homeostasis / Q000502:physiology; D006801:Humans; D008024:Ligands; D051907:Lysosomal Membrane Proteins; D008565:Membrane Proteins; D011971:Receptors, Immunologic / Q000235:genetics* / Q000378:metabolism*; D051116:Receptors, Scavenger; D012795:Sialoglycoproteins; D014162:Transfection; D014168:Transferrin / Q000493:pharmacokinetics
D008076:Cholesterol, HDL; D008024:Ligands; D051907:Lysosomal Membrane Proteins; D008565:Membrane Proteins; D011971:Receptors, Immunologic; D051116:Receptors, Scavenger; C074299:SCARB2 protein, human; D012795:Sialoglycoproteins; D014168:Transferrin